Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01695525
Other study ID # 12945
Secondary ID
Status Completed
Phase Phase 0
First received July 5, 2012
Last updated June 27, 2015
Start date June 2012
Est. completion date March 2015

Study information

Verified date June 2015
Source University of Kansas Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills.

It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate.

Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Diagnosis of recurrent Neurocardiogenic syncope

- At least one episode of syncope or pre-syncopal event in the last 3 months prior to enrollment

Exclusion Criteria:

- Previously established diagnosis of any psychiatric illness.

- Previous history of Coronary Artery Disease, myocardial infarction, congestive heart failure, carotid sinus hypersensitivity

- Established diagnosis of tachy and/or brady arrhythmias, except cardioinhibiotry neurocardiogenic syncope.

- History of pacemaker, ICD or CRT-D implantation.

- Other conditions where Yoga should be avoided are:

1. Pregnant women

2. Subjects with untreated or uncontrolled high blood pressure

3. Subjects with past history of Pnuemothorax.

4. Subjects with severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse.

5. Subjects with carotid stenosis

6. Subjects with history of psychosis (evidence of acute episodes with deep and prolonged meditation) or substance abuse.

7. Subjects with the history of epilepsy ( evidence of acute episodes with deep and prolonged meditation)

8. Subjects with glaucoma

9. Subjects with history of Total Hip Replacement.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Yoga
Includes breathing exercises, postures, and meditation. Participant practices yoga at their home a minimum of 3 times per week for 1 hour per time. Participation can last for up to 1 year.

Locations

Country Name City State
United States University of Kansas Medical Center Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
Dhanunjaya Lakkireddy, MD, FACC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) Differences in the incidence of syncopal spells pre and post Yoga. Baseline to 3 Months No
Primary Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) Differences in the incidence of syncopal spells pre and post Yoga. Baseline to 1 Year No
Primary Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) Differences in the incidence of syncopal symptoms pre and post Yoga. Baseline to 1 Year No
Secondary Change in Heart Health 3 Months, 1 Year No
See also
  Status Clinical Trial Phase
Recruiting NCT05555771 - Paediatric Syncope in the Emergency Department N/A
Completed NCT06038708 - Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
Recruiting NCT03159156 - Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation N/A
Not yet recruiting NCT05572034 - Cardiac Autonomic Denervation for Cardio-inhibitory Syncope N/A
Completed NCT05729724 - Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
Recruiting NCT04595942 - Midodrine and Fludrocortisone for Vasovagal Syncope Phase 3
Completed NCT03903744 - Cardioneuroablation for Reflex Syncope N/A
Completed NCT05782647 - Wearable Monitor in Patients With Syncope N/A
Completed NCT00465439 - Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal N/A
Active, not recruiting NCT01621464 - Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study) Phase 4
Recruiting NCT06440291 - Cardioneuroablation for Reflex Syncope and Exercise Capacity N/A
Recruiting NCT06336031 - Impact of Blood Phobia on Fainting Susceptibility N/A
Completed NCT01617616 - Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects N/A
Recruiting NCT05086679 - Compression Stockings for Treating Vasovagal Syncope Trial N/A
Completed NCT04772755 - Presyncope (Syncope) Prevention Study N/A
Completed NCT03533829 - Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study N/A
Completed NCT05782699 - Detecting Syncope by an Integrated Multisensor Patch-type Recorder N/A
Completed NCT00475462 - The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents N/A
Completed NCT04972123 - The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope Phase 2
Completed NCT00302900 - Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations Phase 2